Role of hypothalamic melanocortin system in adaptation of food intake to food protein increase in mice

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Pillot, Bruno ^a,b,c   Duraffourd, Céline ^a,b,c   Bégeot, Martine ^a,b,c   Joly, Aurélie ^d   Luquet, Serge ^d   Houberdon, Isabelle ^a,b,c   Naville, Danielle ^a,b,c   Vigier, Michèle ^a,b,c   Gautier Stein, Amandine ^a,b,c   Magnan, Christophe ^d   Mithieux, Gilles ^a,b,c  

^a INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; INSULIN; LEPTIN; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CALORIC DENSITY; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DIET; FOOD COMPOSITION; FOOD INTAKE; GENE EXPRESSION; HORMONE ACTION; HORMONE BLOOD LEVEL; HUNGER; HYPOPHAGIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN BLOOD LEVEL; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN INTAKE; ANIMAL; DRUG EFFECT; EATING; GENETICS; HYPOTHALAMUS; MALE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGOUTI; MUS;

AGOUTI-RELATED PROTEIN; ALPHA-MSH; ANIMALS; BODY WEIGHT; DIETARY PROTEINS; EATING; HYPOTHALAMUS; MALE; MICE; PRO-OPIOMELANOCORTIN; RECEPTOR, MELANOCORTIN, TYPE 4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79955539060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019107     Document Type: Article

References (37)

1. Flier JS, (2004) Obesity Wars: Molecular Progress Review. Confronts an Expanding Epidemic. Cell 116: 337-350.
2. Friedman MI, (2000) Obesity in the new millennium. Nature 404: 632-634.
3. Schwartz MW, Morton GJ, (2002) Obesity: keeping hunger at bay. Nature 418: 595-597.
4. Banks WR, Kastin AJ, Huang W, Jaspan JB, Maness LM, (1996) Leptin enters the brain by a saturable system independent of insulin. Peptides 17: 305-311.
5. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660.
6. Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, et al. (2004) Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145: 2607-2612.
7. Moran TH, (2000) Cholecystokinin and satiety: current perspectives. Nutrition 16: 858-865.
8. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, et al. (2002) Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418: 650-654.
9. Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, et al. (2005) The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044: 127-131.
10. Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ, (1981) Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 213: 1036-1037.
11. Koda S, Date Y, Murakami N, Shimbara T, Hanada T, et al. (2005) The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146: 2369-2375.
12. Delaere F, Magnan C, Mithieux G, (2010) Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity. Diabetes Metab 36: 257-262.
13. Elmquist J, Zigman J, Lutter M, (2006) Molecular determinants of energy homeostasis. Am J Psychiatry 163: 1137.
14. Liu H, Kishi T, Roseberry AG, Cai X, Lee CE, et al. (2003) Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci 23: 7143-7154.
15. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, et al. (1993) Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 268: 15174-15179.
16. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, et al. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141.
17. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, et al. (2000) Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106: 253-262.
18. Yang YK, Ollmann MM, Wilson BD, Dickinson C, Yamada T, et al. (1997) Effects of recombinant agouti-signaling protein on melanocortin action. Mol Endocrinol 11: 274-280.
19. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, et al. (1991) Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40: 1397-1403.
20. Mithieux G, Guignot L, Bordet JC, Wiernsperger N, (2002) Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet. Diabetes 51: 139-143.
21. Booth DA, Lovett D, Simson PC, (1970) Subcutaneous dialysis in the study of the effects of nutrients on feeding. Physiol Behav 5: 1201-1203.
22. Rolls BJ, Hetherington M, Burley VJ, (1988) The specificity of satiety: the influence of foods of different macronutrient content on the development of satiety. Physiol Behav 43: 145-153.
23. Gannon MC, Nuttall FQ, (2004) Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes 53: 2375-2382.
24. Gout J, Sarafian D, Tirard J, Blondet A, Vigier M, et al. (2008) Leptin infusion and obesity in mouse cause alterations in the hypothalamic melanocortin system. Obesity 16: 1763-1769.
25. Gout J, Sarafian D, Mutel E, Vigier M, Rajas F, et al. (2010) Metabolic and melanocortin gene expression alterations in male offspring of obese mice. Mol Cell Endocrinol 319: 99-108.
26. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, et al. (2005) Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123: 493-505.
27. Challis BG, Coll AP, Yeo GS, Pinnock SB, Dickson SL, et al. (2004) Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc Natl Acad Sci U S A 101: 4695-4700.
28. Wang H, Storlien LH, Huang XF, (2002) Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Am J Physiol Endocrinol Metab 282: E1352-E1359.
29. Archer ZA, Corneloup J, Rayner DV, Barrett P, Moar KM, et al. (2007) Solid and liquid obesogenic diets induce obe- sity and counter-regulatory changes in hypothalamic gene expression in juvenile Sprague-Dawley rats. J Nutr 137: 1483-1490.
30. Barkeling B, Rossner S, Bjorvell H, (1990) Effects of a high-protein meal (meat) and a high-carbohydrate meal (vegetarian) on satiety measured by automated computerized monitoring of subsequent food intake, motivation to eat and food preferences. Int J Obes 14: 743-751.
31. Mithieux G, (2005) The new functions of the gut in the control of glucose homeostasis. Curr Opin Clin Nutr Metab Care 8: 445-449.
32. Pillot B, Soty M, Gautier-Stein A, Zitoun C, Mithieux G, (2009) Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin. Endocrinology 150: 616-624.
33. Mithieux G, Misery P, Magnan C, Pillot B, Gautier-Stein A, et al. (2005) Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab 2: 321-329.
34. Luquet S, Perez FA, Hnasko TS, Palmiter RD, (2005) NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310: 683-685.
35. Luquet S, Phillips CT, Palmiter RD, (2007) NPY/AgRP neurons are not essential for feeding responses to glucoprivation. Peptides 28: 214-225.
36. Irani BG, Xiang Z, Yarandi HN, Holder JR, Moore MC, et al. (2011) Implication of the melanocortin-3 receptor in the regulation of food intake. Eur J Pharmacol in press.
37. Benoit SC, Air EL, Coolen LM, Strauss R, Jackman A, et al. (2002) The catabolic action of insulin in the brain is mediated by melanocortins. J Neurosci 22: 9048-9052.